Global Healthcare CRO Market 2023-2029

The global healthcare CRO market is anticipated to increase by USD 20.7 billion till 2029 at an average annual growth of 6.2 percent as per the latest market estimates.

A contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biological assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and real world evidence. The global healthcare CRO market is anticipated to increase by USD 20.7 billion till 2029 at an average annual growth of 6.2 percent as per the latest market estimates. Significant increase in drug and medical device R&D and increase in private biotechnology organizations are the major factors driving the growth of the healthcare CRO market.Significant increase in drug and medical device R&D and increase in private biotechnology organizations are the major factors driving the growth of the healthcare CRO market.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global healthcare CRO market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the stage, service type, end user, and region. The global market for healthcare CRO can be segmented by stage: drug discovery, pre-clinical, clinical. The clinical segment is estimated to account for the largest share of the global healthcare CRO market. Healthcare CRO market is further segmented by service type: bio-statistics, clinical monitoring, data management, investigator payments, laboratory, medical writing, patient and site recruitment, project management and clinical supply management, quality management/assurance, regulatory and medical affairs, technology services, others. The clinical monitoring segment held the largest revenue share in 2022. Based on end user, the healthcare CRO market is segmented into: pharmaceutical & biopharmaceutical companies, medical device companies, others. Globally, the pharmaceutical & biopharmaceutical companies segment made up the largest share of the healthcare CRO market. On the basis of region, the healthcare CRO market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Asia-Pacific was the largest contributor to the global healthcare CRO market in 2022.

Market Segmentation
By stage: drug discovery, pre-clinical, clinical
By service type: bio-statistics, clinical monitoring, data management, investigator payments, laboratory, medical writing, patient and site recruitment, project management and clinical supply management, quality management/assurance, regulatory and medical affairs, technology services, others
By end user: pharmaceutical & biopharmaceutical companies, medical device companies, others
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The market research report covers the analysis of key stake holders of the global healthcare CRO market. Some of the leading players profiled in the report include Aragen Life Sciences Ltd., BioTelemetry, Inc. (Koninklijke Philips N.V.), Charles River Laboratories, Inc., CTI Clinical Trial and Consulting, Inc., Evotec A.G., ICON plc, IQVIA Inc., Labcorp Drug Development Inc, Medidata Solutions, Inc., Medpace Holdings, Inc., PAREXEL International Corporation, Pharmaron Beijing Co., Ltd., PPD, Inc., PSI CRO AG, SGS S.A., Syneos Health, Inc., Syngene International Limited, WuXi AppTec, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant



Scope of the Report
• To analyze and forecast the market size of the global healthcare CRO market.
• To classify and forecast the global healthcare CRO market based on stage, service type, end user, region.
• To identify drivers and challenges for the global healthcare CRO market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global healthcare CRO market.
• To identify and analyze the profile of leading players operating in the global healthcare CRO market.

Why Choose This Report
• Gain a reliable outlook of the global healthcare CRO market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • TABLE OF CONTENTS
  • FIGURES AND TABLES
  • PART 1. INTRODUCTION
  • · Report description
  • · Objectives of the study
  • · Market segment
  • · Years considered for the report
  • · Currency
  • · Key target audience
  • PART 2. METHODOLOGY
  • PART 3. EXECUTIVE SUMMARY
  • PART 4. MARKET OVERVIEW
  • · Introduction
  • · Drivers
  • · Restraints
  • PART 5. MARKET BREAKDOWN BY STAGE
  • · Drug discovery
  • · Pre-clinical
  • · Clinical
  • PART 6. MARKET BREAKDOWN BY SERVICE TYPE
  • · Bio-statistics
  • · Clinical monitoring
  • · Data management
  • · Investigator payments
  • · Laboratory
  • · Medical writing
  • · Patient and site recruitment
  • · Project management and clinical supply management
  • · Quality management/assurance
  • · Regulatory and medical affairs
  • · Technology services
  • · Others
  • PART 7. MARKET BREAKDOWN BY END USER
  • · Pharmaceutical & biopharmaceutical companies
  • · Medical device companies
  • · Others
  • PART 8. MARKET BREAKDOWN BY REGION
  • · North America
  • · Europe
  • · Asia-Pacific
  • · MEA (Middle East and Africa)
  • · Latin America
  • PART 9. KEY COMPANIES
  • · Aragen Life Sciences Ltd.
  • · BioTelemetry, Inc. (Koninklijke Philips N.V.)
  • · Charles River Laboratories, Inc.
  • · CTI Clinical Trial and Consulting, Inc.
  • · Evotec A.G.
  • · ICON plc
  • · IQVIA Inc.
  • · Labcorp Drug Development Inc
  • · Medidata Solutions, Inc.
  • · Medpace Holdings, Inc.
  • · PAREXEL International Corporation
  • · Pharmaron Beijing Co., Ltd.
  • · PPD, Inc.
  • · PSI CRO AG
  • · SGS S.A.
  • · Syneos Health, Inc.
  • · Syngene International Limited
  • · WuXi AppTec, Inc.
  • *REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
  • DISCLAIMER

Logo

Global Healthcare CRO Market 2023-2029

Contact usWe are friendly and approachable, give us a call.